An Advanced Stability-Indicating RP-UPLC Method for Rapid Quantification of Vimseltinib in Bulk and Pharmaceutical Formulations

Authors

  • B. Pavani Associate Professor, Department of Pharmaceutical Analysis, Vasavi Institute of Pharmaceutical Sciences, Kadapa 516247

Keywords:

Vimseltinib, RP-UPLC, validation, Method Development.

Abstract

A simple, Accurate, precise method was developed for the estimation of the Vimseltinib in bulk and pharmaceutical dosage form RP-UPLC technique. Chromatographic conditions used are stationary phase CHS 50mm x 2.1 mm, 1.8m ,Mobile containing Buffer 0.1% OPA: Acetonitrile taken in the ratio 70:30 was pumped through column at a flow rate of 0.3 ml/min. Buffer used in this method was 0.1% OPA buffer. Temperature was maintained at 30°C. Optimized wavelength selected was 264.0 nm. Retention time of Vimseltinib was found to be 0.848 min. %RSD of the Vimseltinib was and found to be 0.4%. %Recovery was obtained as 99.52% for Vimseltinib. LOD and LOQ are 0.01 µg/ml and 0.04 µg/ml. %Assay was obtained as 99.50% for Vimseltinib. Regression equation of Vimseltinib is y = 7260.5x + 329. Retention times were decreased and that run time was decreased, so the method developed was simple and economical that can be adopted in regular Quality control test in Industries.

Downloads

Published

2026-09-07

How to Cite

B. Pavani. (2026). An Advanced Stability-Indicating RP-UPLC Method for Rapid Quantification of Vimseltinib in Bulk and Pharmaceutical Formulations. World Journal of Pharmaceutical Sciences, 14(01). Retrieved from https://www.wjpsonline.com/index.php/wjps/article/view/2228

Issue

Section

Research Article